PROspective Prostate Cancer Infrastructure: study protocol for the ProPCI ‘trials within cohorts’ study
Abstract Introduction The diagnostic and therapeutic landscape for high-risk localised prostate cancer and synchronous metastatic hormone-sensitive prostate cancer (mHSPC) is rapidly evolving, driven by advances in imaging, risk stratification and systemic therapies, including the advent of precision medicine. High-qua...